Stock Market | The Underground Newswire

JD Rucker

All indications from corporate media tell us Big Pharma is a safe investment as Pandemic Panic Theater continues to rage. But the biggest investors are pulling out now. Why?

For the average investor, there seems to be a future in Big Pharma. The world is engulfed by Pandemic Panic Theater as new jabs, boosters, and pills continue to roll out to fight Covid. Mandates are still in place for millions of people and threats of more still loom. This week, a national vaccine passport quietly moved forward.

But the elite investors are inexplicably pulling out. Stock prices for the major vaccine manufacturers are plummeting as a result, leaving many smaller investors wondering if this is a long-term trend or a blip. According to The Deseret Review:

Wall Street investors are dumping their Moderna and Pfizer stock faster than the world can drop the mandates. Moderna is down 70 percent from its high, while Pfizer is off 19 percent. Former Blackrock Executive and investment adviser Edward Dowd calls for Moderna to go to zero and Pfizer to end under ten dollars per share.

How is this possible given that Pfizer now enjoys record earnings per share and a market capitalization of some $270 billion, making it the 29th largest corporation globally? With nothing but profits in sight for the Pharmaceutical giant, what could be the problem?

After all, in December, a Forbes‘ headline read, “The Vaccine Maker Can Dominate The Covid Market For Years to Come, Wells Fargo Predicts.” In addition to the enormously profitable mRNA vaccines, Pfizer is rolling out potent antivirals like Paxlovid, which could earn $22 billion in 2022.

Compared to the $81 billion in 2021 revenue, the earnings from the vaccines and the antivirals could top $102 billion for 2022, which is music to shareholders’ ears. However some are hearing shrieks, and these happen to be Wall Street’s finest, the smart money that beats the rest of the herd to the exits like clockwork.

These sophisticated investors make it their business to not go with the conventional wisdom but to do their own research, which often pays spectacular dividends.

The prevailing conspiracy theory explaining this swift change in money confidence claims the powers-that-be have initiated the next stage of their plan to bring forth The Great Reset. Russia in Ukraine, perhaps followed by China in Taiwan, and other conflicts across the globe could send America’s and the world’s economies into full-blown collapse.

Accounts are being frozen and money is losing stability, whether by Canada with their draconian reactions to the Freedom Convoy, sanctions currently being placed on powerful Russians, or the odd push for green energy. This all portends a near-future strong reaction from the people, a reaction that could usher in the “need” for a universal cashless society and government-controlled digital currency.

In other words, whatever the big investors know about Big Pharma stocks, it’s very likely that the agenda is not one the people of the world will enjoy. Machinations of globalist elites invariably harm the masses even as they’re promoted as beneficial to all. The precepts of The Great Reset demand an unwitting embrace of Neo-Marxism disguised with colorful terms like “stakeholder capitalism” and “the end of poverty.”

What they don’t tell you is that the “equity” they promote is designed to make us all equally destitute. They want the vast majority of people are beholden to the powers-that-be in order to survive.

We’ll be keeping a very close eye on how the big money is moving. Every action by the globalist elite going forward will be calculated and pre-planned. It’s time for the rest of us to prepare for what’s to come.

Eric Quintanar
May 14th, 2020

Federal law enforcement officials have questioned Senator Dianne Feinstein (D-CA) over stock trades Richard Blum, the senator’s husband, made ahead of the coronavirus market crash. The senator’s husband reportedly sold between $1.5 million and $6 million in biotech stock from January 31 to February 18.

Tom Mentzer, a spokesperson for Feinstein, told the San Francisco Chronicle on Thursday that the California senator turned over documents that show she wasn’t involved in her husband’s stock trades, and “voluntarily” answered “questions to set the record straight.”

The spokesperson told The New York Times in mid-March, after reports emerged that four senators sold stocks before the market tanked, that Feinstein’s assets are in a blind trust. Feinstein tweeted on March 20 that her assets have been in a blind trust throughout her senate career, which began in 1992.

During my Senate career I’ve held all assets in a blind trust of which I have no control. Reports that I sold any assets are incorrect, as are reports that I was at a January 24 briefing on coronavirus, which I was unable to attend.

Under Senate rules I report my husband’s financial transactions. I have no input into his decisions. My husband in January and February sold shares of a cancer therapy company. This company is unrelated to any work on the coronavirus and the sale was unrelated to the situation.

Allogene Therapeutics, the biotech company whose shares her husband traded, closed at $21.72 per share on January 31 and $24.25 on February 18. The company is currently trading at $42.55 per share.

Feinstein, the former chair of the Senate Intelligence Committee, disclosed the conversation with law enforcement officials as Senator Richard Burr (R-NC) agreed to step down from his position as Senate Intelligence Chair amidst an investigation into his stock activities on February 13.

In a statement, Senate Majority Leader Mitch McConnell (R-KY) said Burr approached him with the decision on Thursday morning, and they both agreed it “would be in the best interests of the committee.”

As the Los Angeles Times previously reported, the FBI obtained a search warrant for the senator and confiscated his cell phone. Law enforcement officials told the news agency that they were looking at his conversations with his stock broker and in previous days served a warrant to Apple in order to access information on the senator’s iCloud account.

Information about Burr’s stock activities was unearthed in late March by ProPublica, which reported that the senator and his wife “sold off a significant percentage of his stocks” over the course of 33 transactions in a single day. The trades amounted to between $628,000 and $1.72 million, reports the news agency.

Burr told reporters on Thursday that the he has been complying with the investigation since the beginning, and that “everybody ought to let this investigation play out,” reports CNBC. The senator also said he was stepping down as chairman because the ongoing investigation was a “distraction to the hard work of the committee.”

Burr has previously said that he made his financial decisions based on publicly available information, specifically referencing reports at CNBC daily health, according to The Associated Press.